ARIAD Pharmaceuticals Inc logo

ARIA - ARIAD Pharmaceuticals Inc News Story

$23.99 0.0  0.0%

Last Trade - 15/02/17

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £135.1m
Position in Universe th / 6851

BRIEF-Ariad Pharma says termination fee for Takeda deal will be $169 mln

Tue 10th January, 2017 8:11pm
Jan 10 (Reuters) - Ariad Pharmaceuticals Inc:  
    * If deal is terminated by co, to enter definitive agreement 
with respect to superior proposal, co to pay termination fee of 
$169 million  
Source text -  
Further company coverage:  ARIA.O  4502.T  
 (( ;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.